Investor
Brummer Multi-Strategy AB
CIK 0002003159 · filed 2026-05-06 · SEC filing
13F book
$24M
Positions
8
4 new · 7 sold
Largest name
28.1%
Cbre Group, Inc. · CBRE
Est. mark
−$724.5K
Price effect on 4 names still held. Flow $8.2M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Cbre Group, Inc. | CBRE | 49.8K | $6.75M | 28.1% | — | New |
| Agree Rlty Corp | — | 87.1K | $6.57M | 27.3% | — | New |
| Arvinas, Inc. | ARVN | 285.1K | $3.02M | 12.6% | −$209.6K | Added$1.05M |
| Abivax Sa | — | 22.4K | $2.5M | 10.4% | −$337.9K | Added$558.8K |
| Maravai Lifesciences Hldgs I | — | 759.7K | $2.15M | 9.0% | −$192.2K | Added$662.5K |
| Wp Carey Inc | — | 28.5K | $1.94M | 8.1% | — | New |
| Ataibeckley Inc Com Shs | ATAI | 275.4K | $974.9K | 4.1% | — | New |
| Klotho Neurosciences Inc | — | 370K | $122.1K | 0.5% | $15.2K | Cut−$53.2K |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.